Loading organizations...
§ Private Profile · Boston, MA, USA
Cutting-edge genomics and molecular diagnostics company.
NuProbe has raised $103.0M across 3 funding rounds.
NuProbe has raised $103.0M in total across 3 funding rounds.
NuProbe has raised $103.0M in total across 3 funding rounds.
NuProbe's investors include Chen Bing, Jason Zhou, Li Yuhui, Deguan Capital, Haoreng Capital, Hongshan Capital Group (Sequoia Capital China), Pappas Capital, Yonghua Capital, Wen Chen, Juming Capital, Panlin Capital, Ruomu Capital.
NuProbe has raised $103.0M across 3 funding rounds. Most recently, it raised $50.0M Other Equity in June 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 3, 2022 | $50M Venture Round | Chen Bing, Jason Zhou, LI Yuhui | Deguan Capital, Haoreng Capital, Hongshan Capital Group (Sequoia Capital China), Pappas Capital, Yonghua Capital | Announced |
| Jan 11, 2021 | $42M Venture Round | WEN Chen | Hongshan Capital Group (Sequoia Capital China), Juming Capital, Panlin Capital, Ruomu Capital, Serica Partners, Taifu Capital, Tuobang Capital | Announced |
| Apr 23, 2018 | $11M Series A | Neil Shen, Victor Chenyang SHI | WuXi AppTec | Announced |